{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:24:25Z","timestamp":1783405465792,"version":"3.54.6"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Yangzhou University International Academic Exchange Fund"},{"name":"Jiangsu Province Capability Improvement Project through Science, Technology and Education; Jiangsu Provincial Medical Key Discipline Cultivation Unit","award":["JSDW202235"],"award-info":[{"award-number":["JSDW202235"]}]},{"name":"Clinical Research Fund of Hengrui Medicine, Collaborative Innovation Center for Individualized Cancer Medicine, Nanjing Medical University","award":["2024CICCPMHR020"],"award-info":[{"award-number":["2024CICCPMHR020"]}]},{"name":"\u201c123\u201d advantageous disciplines, core technologies of the Second Affiliated Hospital of Nanjing Medical University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04326-y","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T18:57:23Z","timestamp":1778180243000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated analyses reveal a potential role for PFKFB4 in M2 macrophage polarization and hepatocellular carcinoma progression"],"prefix":"10.1186","volume":"26","author":[{"given":"Siying","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinqiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zibo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6469-2320","authenticated-orcid":false,"given":"Xuyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"chen Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1893-371X","authenticated-orcid":false,"given":"Zhaoxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"4326_CR1","doi-asserted-by":"publisher","first-page":"e1288","DOI":"10.1016\/S2214-109X(18)30411-X","volume":"6","author":"B Cao","year":"2018","unstructured":"Cao B, Bray F, Ilbawi A, et al. Effect on longevity of one-third reduction in premature mortality from non-communicable diseases by 2030: a global analysis of the Sustainable Development Goal health target. Lancet Glob Health. 2018;6:e1288\u201396.","journal-title":"Lancet Glob Health"},{"key":"4326_CR2","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41571-021-00514-z","volume":"18","author":"I Soerjomataram","year":"2021","unstructured":"Soerjomataram I, Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020\u20132070. Nat Rev Clin Oncol. 2021;18:663\u201372.","journal-title":"Nat Rev Clin Oncol"},{"key":"4326_CR3","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/s41419-023-06358-y","volume":"14","author":"S Chen","year":"2023","unstructured":"Chen S, Zhou B, Huang W, et al. The deubiquitinating enzyme USP44 suppresses hepatocellular carcinoma progression by inhibiting Hedgehog signaling and PDL1 expression. Cell Death Dis. 2023;14:830.","journal-title":"Cell Death Dis"},{"key":"4326_CR4","doi-asserted-by":"publisher","first-page":"12369","DOI":"10.1002\/jcp.28058","volume":"234","author":"H Mollaei","year":"2019","unstructured":"Mollaei H, Safaralizadeh R, Rostami Z. MicroRNA replacement therapy in cancer. J Cell Physiol. 2019;234:12369\u201384.","journal-title":"J Cell Physiol"},{"key":"4326_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrc3038","volume":"11","author":"WH Koppenol","year":"2011","unstructured":"Koppenol WH, Bounds PL, Dang CV. Otto Warburg\u2019s contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011;11:325\u201337.","journal-title":"Nat Rev Cancer"},{"key":"4326_CR6","doi-asserted-by":"publisher","first-page":"1056694","DOI":"10.3389\/fmicb.2022.1056694","volume":"13","author":"D Hu","year":"2022","unstructured":"Hu D, Zhang Y, Liu D, et al. PFK2\/FBPase-2 is a potential target for metabolic engineering in the filamentous fungus Myceliophthora thermophila. Front Microbiol. 2022;13:1056694.","journal-title":"Front Microbiol"},{"key":"4326_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0378-1119(99)00037-2","volume":"229","author":"A Manzano","year":"1999","unstructured":"Manzano A, Perez JX, Nadal M, et al. Cloning, expression and chromosomal localization of a human testis 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase gene. Gene. 1999;229:83\u20139.","journal-title":"Gene"},{"key":"4326_CR8","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1042\/BJ20040752","volume":"381","author":"MH Rider","year":"2004","unstructured":"Rider MH, Bertrand L, Vertommen D, et al. 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis. Biochem J. 2004;381:561\u201379.","journal-title":"Biochem J"},{"key":"4326_CR9","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.yexmp.2009.01.003","volume":"86","author":"A Yalcin","year":"2009","unstructured":"Yalcin A, Telang S, Clem B, et al. Regulation of glucose metabolism by 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatases in cancer. Exp Mol Pathol. 2009;86:174\u20139.","journal-title":"Exp Mol Pathol"},{"key":"4326_CR10","doi-asserted-by":"publisher","first-page":"6248","DOI":"10.7150\/thno.28721","volume":"8","author":"R Gao","year":"2018","unstructured":"Gao R, Li D, Xun J, et al. CD44ICD promotes breast cancer stemness via PFKFB4-mediated glucose metabolism. Theranostics. 2018;8:6248\u201362.","journal-title":"Theranostics"},{"key":"4326_CR11","doi-asserted-by":"publisher","first-page":"6670","DOI":"10.18632\/oncotarget.2213","volume":"5","author":"J Chesney","year":"2014","unstructured":"Chesney J, Clark J, Klarer AC, et al. Fructose-2,6-bisphosphate synthesis by 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase 4 (PFKFB4) is required for the glycolytic response to hypoxia and tumor growth. Oncotarget. 2014;5:6670\u201386.","journal-title":"Oncotarget"},{"key":"4326_CR12","doi-asserted-by":"publisher","first-page":"9440","DOI":"10.1074\/jbc.M113.529990","volume":"289","author":"Y Imbert-Fernandez","year":"2014","unstructured":"Imbert-Fernandez Y, Clem BF, O\u2019Neal J, et al. Estradiol stimulates glucose metabolism via 6-phosphofructo-2-kinase (PFKFB3). J Biol Chem. 2014;289:9440\u20138.","journal-title":"J Biol Chem"},{"key":"4326_CR13","doi-asserted-by":"publisher","first-page":"102610","DOI":"10.1016\/j.ebiom.2019.102610","volume":"51","author":"S Xia","year":"2020","unstructured":"Xia S, Pan Y, Liang Y, et al. The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma. EBioMedicine. 2020;51:102610.","journal-title":"EBioMedicine"},{"key":"4326_CR14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"Mantovani A, Marchesi F, Malesci A, et al. Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol. 2017;14:399\u2013416.","journal-title":"Nat Rev Clin Oncol"},{"key":"4326_CR15","doi-asserted-by":"crossref","unstructured":"Singer M, Zhang Z, Dayyani F et al. (2024) Modulation of Tumor-Associated Macrophages to Overcome Immune Suppression in the Hepatocellular Carcinoma Microenvironment. Cancers (Basel)2024; 17.(1):66.","DOI":"10.3390\/cancers17010066"},{"key":"4326_CR16","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1002\/cac2.12345","volume":"42","author":"K Cheng","year":"2022","unstructured":"Cheng K, Cai N, Zhu J, et al. Tumor-associated macrophages in liver cancer: From mechanisms to therapy. Cancer Commun (Lond). 2022;42:1112\u201340.","journal-title":"Cancer Commun (Lond)"},{"key":"4326_CR17","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98\u2013102.","journal-title":"Nucleic Acids Res"},{"key":"4326_CR18","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:pl1.","journal-title":"Sci Signal"},{"key":"4326_CR19","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1093\/nar\/gkv873","volume":"44","author":"Z Ji","year":"2016","unstructured":"Ji Z, Vokes SA, Dang CV, et al. Turning publicly available gene expression data into discoveries using gene set context analysis. Nucleic Acids Res. 2016;44:e8.","journal-title":"Nucleic Acids Res"},{"key":"4326_CR20","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48:W509\u201314.","journal-title":"Nucleic Acids Res"},{"key":"4326_CR21","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.jhep.2021.06.028","volume":"75","author":"L Ma","year":"2021","unstructured":"Ma L, Wang L, Khatib SA, et al. Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Hepatol. 2021;75:1397\u2013408.","journal-title":"J Hepatol"},{"key":"4326_CR22","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.acthis.2016.05.002","volume":"118","author":"M Jurikova","year":"2016","unstructured":"Jurikova M, Danihel L, Polak S, et al. Ki67, PCNA, and MCM proteins: Markers of proliferation in the diagnosis of breast cancer. Acta Histochem. 2016;118:544\u201352.","journal-title":"Acta Histochem"},{"issue":"Suppl 4","key":"4326_CR23","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"CH Chin","year":"2014","unstructured":"Chin CH, Chen SH, Wu HH, et al. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8(Suppl 4):S11.","journal-title":"BMC Syst Biol"},{"key":"4326_CR24","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498\u2013504.","journal-title":"Genome Res"},{"key":"4326_CR25","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, Jones MR, Rouillard AD, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90\u201397.","journal-title":"Nucleic Acids Res"},{"key":"4326_CR26","doi-asserted-by":"publisher","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","volume":"46","author":"SV Vasaikar","year":"2018","unstructured":"Vasaikar SV, Straub P, Wang J, et al. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 2018;46:D956\u201363.","journal-title":"Nucleic Acids Res"},{"key":"4326_CR27","doi-asserted-by":"publisher","first-page":"e1434467","DOI":"10.1080\/2162402X.2018.1434467","volume":"7","author":"M Farhad","year":"2018","unstructured":"Farhad M, Rolig AS, Redmond WL. The role of Galectin-3 in modulating tumor growth and immunosuppression within the tumor microenvironment. Oncoimmunology. 2018;7:e1434467.","journal-title":"Oncoimmunology"},{"key":"4326_CR28","doi-asserted-by":"publisher","first-page":"e19296","DOI":"10.1016\/j.heliyon.2023.e19296","volume":"9","author":"S Tan","year":"2023","unstructured":"Tan S, Tang H, Wang Y, et al. Tumor cell-derived exosomes regulate macrophage polarization: Emerging directions in the study of tumor genesis and development. Heliyon. 2023;9:e19296.","journal-title":"Heliyon"},{"key":"4326_CR29","doi-asserted-by":"publisher","first-page":"1251648","DOI":"10.3389\/fimmu.2023.1251648","volume":"14","author":"L Yang","year":"2023","unstructured":"Yang L, Han P, Cui T, et al. M2 macrophage inhibits the antitumor effects of Lenvatinib on intrahepatic cholangiocarcinoma. Front Immunol. 2023;14:1251648.","journal-title":"Front Immunol"},{"key":"4326_CR30","doi-asserted-by":"publisher","first-page":"223","DOI":"10.5662\/wjm.v13.i4.223","volume":"13","author":"Y Xu","year":"2023","unstructured":"Xu Y, Hou YY, Wu Z, et al. Comprehensive analysis of cell-extracellular matrix protein Ras suppressor-1 in function and prognosis of gastrointestinal cancers. World J Methodol. 2023;13:223\u201337.","journal-title":"World J Methodol"},{"key":"4326_CR31","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12935-023-03088-1","volume":"23","author":"JS Chen","year":"2023","unstructured":"Chen JS, Teng YN, Chen CY, et al. A novel STAT3\/ NFkappaB p50 axis regulates stromal-KDM2A to promote M2 macrophage-mediated chemoresistance in breast cancer. Cancer Cell Int. 2023;23:237.","journal-title":"Cancer Cell Int"},{"issue":"3696511","key":"4326_CR32","doi-asserted-by":"publisher","first-page":"eaay4014","DOI":"10.1126\/science.aay4014","volume":"2020","author":"B Pulendran","year":"2020","unstructured":"Pulendran B, Davis MM. The science and medicine of human immunology. Science. 2020;2020(3696511):eaay4014.","journal-title":"Science"},{"key":"4326_CR33","doi-asserted-by":"crossref","unstructured":"Alhujaily M. (2024) Glyoxalase System in Breast and Ovarian Cancers: Role of MEK\/ERK\/SMAD1 Pathway. Biomolecules 14.","DOI":"10.3390\/biom14050584"},{"key":"4326_CR34","doi-asserted-by":"publisher","first-page":"15155","DOI":"10.1073\/pnas.1417549111","volume":"111","author":"M Drosten","year":"2014","unstructured":"Drosten M, Sum EY, Lechuga CG, et al. Loss of p53 induces cell proliferation via Ras-independent activation of the Raf\/Mek\/Erk signaling pathway. Proc Natl Acad Sci U S A. 2014;111:15155\u201360.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4326_CR35","first-page":"469","volume":"22","author":"F Chang","year":"2003","unstructured":"Chang F, Steelman LS, Shelton JG, et al. Regulation of cell cycle progression and apoptosis by the Ras\/Raf\/MEK\/ERK pathway (Review). Int J Oncol. 2003;22:469\u201380.","journal-title":"Int J Oncol"},{"key":"4326_CR36","doi-asserted-by":"publisher","first-page":"111873","DOI":"10.1016\/j.biopha.2021.111873","volume":"141","author":"M Malekan","year":"2021","unstructured":"Malekan M, Ebrahimzadeh MA, Sheida F. The role of Hypoxia-Inducible Factor-1alpha and its signaling in melanoma. Biomed Pharmacother. 2021;141:111873.","journal-title":"Biomed Pharmacother"},{"key":"4326_CR37","doi-asserted-by":"crossref","unstructured":"Capece D, Fischietti M, Verzella D et al. (2013) The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages. Biomed Res Int 2013: 187204.","DOI":"10.1155\/2013\/187204"},{"key":"4326_CR38","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1182\/blood-2004-03-1109","volume":"104","author":"C Murdoch","year":"2004","unstructured":"Murdoch C, Giannoudis A, Lewis CE. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood. 2004;104:2224\u201334.","journal-title":"Blood"},{"key":"4326_CR39","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/bph.13139","volume":"173","author":"R Orihuela","year":"2016","unstructured":"Orihuela R, McPherson CA, Harry GJ. Microglial M1\/M2 polarization and metabolic states. Br J Pharmacol. 2016;173:649\u201365.","journal-title":"Br J Pharmacol"},{"key":"4326_CR40","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1158\/0008-5472.CAN-05-2351","volume":"66","author":"HJ Knowles","year":"2006","unstructured":"Knowles HJ, Mole DR, Ratcliffe PJ, et al. Normoxic stabilization of hypoxia-inducible factor-1alpha by modulation of the labile iron pool in differentiating U937 macrophages: effect of natural resistance-associated macrophage protein 1. Cancer Res. 2006;66:2600\u20137.","journal-title":"Cancer Res"},{"key":"4326_CR41","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/cdd.2014.212","volume":"22","author":"L Li","year":"2015","unstructured":"Li L, Ng DS, Mah WC, et al. A unique role for p53 in the regulation of M2 macrophage polarization. Cell Death Differ. 2015;22:1081\u201393.","journal-title":"Cell Death Differ"},{"key":"4326_CR42","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/hep.29086","volume":"67","author":"JK Heimbach","year":"2018","unstructured":"Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67:358\u201380.","journal-title":"Hepatology"},{"key":"4326_CR43","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.3748\/wjg.v29.i6.1054","volume":"29","author":"DS Mandlik","year":"2023","unstructured":"Mandlik DS, Mandlik SK, Choudhary HB. Immunotherapy for hepatocellular carcinoma: Current status and future perspectives. World J Gastroenterol. 2023;29:1054\u201375.","journal-title":"World J Gastroenterol"},{"key":"4326_CR44","doi-asserted-by":"publisher","first-page":"109038","DOI":"10.1016\/j.jnutbio.2022.109038","volume":"107","author":"C Jia","year":"2022","unstructured":"Jia C, Zhao Y, Huang H, et al. Apigenin sensitizes radiotherapy of mouse subcutaneous glioma through attenuations of cell stemness and DNA damage repair by inhibiting NF-kappaB\/HIF-1alpha-mediated glycolysis. J Nutr Biochem. 2022;107:109038.","journal-title":"J Nutr Biochem"},{"key":"4326_CR45","doi-asserted-by":"crossref","unstructured":"Yamazaki H, Onoyama S, Gotani S et al. (2023) Influence of the Hypoxia-Activated Prodrug Evofosfamide (TH-302) on Glycolytic Metabolism of Canine Glioma: A Potential Improvement in Cancer Metabolism. Cancers (Basel).2023;15(23):5537.","DOI":"10.3390\/cancers15235537"},{"key":"4326_CR46","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1186\/s12951-023-02260-z","volume":"21","author":"L Lei","year":"2023","unstructured":"Lei L, Dai W, Man J, et al. Lonidamine liposomes to enhance photodynamic and photothermal therapy of hepatocellular carcinoma by inhibiting glycolysis. J Nanobiotechnol. 2023;21:482.","journal-title":"J Nanobiotechnol"},{"key":"4326_CR47","doi-asserted-by":"publisher","first-page":"16284","DOI":"10.1038\/s41598-023-43619-4","volume":"13","author":"X Gu","year":"2023","unstructured":"Gu X, Dai X, Huang Y, et al. Differential roles of highly expressed PFKFB4 in colon adenocarcinoma patients. Sci Rep. 2023;13:16284.","journal-title":"Sci Rep"},{"key":"4326_CR48","doi-asserted-by":"publisher","first-page":"4384","DOI":"10.1038\/s41388-021-01871-w","volume":"40","author":"TH Truong","year":"2021","unstructured":"Truong TH, Benner EA, Hagen KM, et al. PELP1\/SRC-3-dependent regulation of metabolic PFKFB kinases drives therapy resistant ER(+) breast cancer. Oncogene. 2021;40:4384\u201397.","journal-title":"Oncogene"},{"key":"4326_CR49","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.urolonc.2010.08.018","volume":"30","author":"SJ Yun","year":"2012","unstructured":"Yun SJ, Jo SW, Ha YS, et al. PFKFB4 as a prognostic marker in non-muscle-invasive bladder cancer. Urol Oncol. 2012;30:893\u20139.","journal-title":"Urol Oncol"},{"key":"4326_CR50","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s12935-023-03169-1","volume":"23","author":"S Zheng","year":"2023","unstructured":"Zheng S, Li H, Li Y, et al. The emerging role of glycolysis and immune evasion in gastric cancer. Cancer Cell Int. 2023;23:317.","journal-title":"Cancer Cell Int"},{"key":"4326_CR51","first-page":"916","volume":"60","author":"S Walenta","year":"2000","unstructured":"Walenta S, Wetterling M, Lehrke M, et al. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res. 2000;60:916\u201321.","journal-title":"Cancer Res"},{"key":"4326_CR52","doi-asserted-by":"publisher","first-page":"1417521","DOI":"10.3389\/fimmu.2024.1417521","volume":"15","author":"W Guihu","year":"2024","unstructured":"Guihu W, Wei D, Hailong Z, et al. Activation of MEK-ERK-c-MYC signaling pathway promotes splenic M2-like macrophage polarization to inhibit PHcH-liver cirrhosis. Front Immunol. 2024;15:1417521.","journal-title":"Front Immunol"},{"key":"4326_CR53","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s42003-022-03369-x","volume":"5","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Takano T, Li X, et al. beta-elemene regulates M1-M2 macrophage balance through the ERK\/JNK\/P38 MAPK signaling pathway. Commun Biol. 2022;5:519.","journal-title":"Commun Biol"},{"key":"4326_CR54","doi-asserted-by":"crossref","unstructured":"Huang R, Ning Q, Zhao J et al. (2023) Targeting ENPP1 for cancer immunotherapy: Killing two birds with one stone. Biochem Pharmacol.2024;220:116006.","DOI":"10.1016\/j.bcp.2023.116006"},{"key":"4326_CR55","doi-asserted-by":"publisher","first-page":"157307","DOI":"10.1016\/j.phymed.2025.157307","volume":"148","author":"Y Gao","year":"2025","unstructured":"Gao Y, Gong Y, Song X, et al. Dihydroartemisinin inhibits histone lactylation through YAP1 to act as a \u2018hot\u2019 switch for \u2018cold\u2019 tumor in hepatocellular carcinoma. Phytomedicine. 2025;148:157307.","journal-title":"Phytomedicine"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04326-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04326-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04326-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:02:53Z","timestamp":1783404173000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-026-04326-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4326"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04326-y","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"7 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Second Affiliated Hospital of Nanjing Medical University (2023-KY-209-01) and (2025-KY-285-01). The study was performed in accordance with the Helsinki Declaration and Rules of Good Clinical Practice. All participants signed written informed consents after fully explained. All animal experiments in this study were approved by the Animal Ethics Committee of Nanjing Medical University (IACUC-2410072). The experiments were conducted in strict accordance with the Declaration of Helsinki and the Guidelines for Animal Research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"251"}}